PCVX
Vaxcyte, Inc.$59.08-0.46 (-0.77%)Prev Close$59.54·MCap$8.59B·P/E—·Vol1.31M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
16
$7.78M
◆
Net Activity
Net Seller
$7.78M
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Vaxcyte, Inc. (PCVX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 16 insider sales totaling $7.78M. The most recent insider transaction was by Wassil Jim (officer: EVP, Chief Scientific Ofc, COO), who sold $163.9K worth of shares on Sep 9, 2026. Vaxcyte, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $8.59B.
PCVX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Wassil Jim | officer: EVP, Chief Scientific Ofc, COO | Sell | 2,715 | $60.35 | $163.9K | 152,228 |
| Sep 2, 2026 | Wassil Jim | officer: CHIEF OPERATING OFFICER | Sell | 3,477 | $61.07 | $212.4K | 156,981 |
| Aug 5, 2026 | Dhaliwal Harpreet S. | officer: Chief Technical Ops Officer | Sell | 17,000 | $55.00 | $935.1K | 76,756 |
| Aug 5, 2026 | GUGGENHIME ANDREW | officer: PRESIDENT AND CFO | Sell | 10,000 | $53.89 | $538.9K | 108,220 |
| Aug 5, 2026 | Wassil Jim | officer: CHIEF OPERATING OFFICER | Sell | 2,250 | $53.86 | $121.2K | 158,930 |
| Jul 28, 2026 | PICKERING GRANT | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 18,198 | $55.63 | $1.01M | 457,662 |
| Jul 6, 2026 | Wassil Jim | officer: CHIEF OPERATING OFFICER | Sell | 2,250 | $56.33 | $126.7K | 157,222 |
| Jul 6, 2026 | GUGGENHIME ANDREW | officer: PRESIDENT AND CFO | Sell | 10,000 | $57.28 | $572.8K | 106,482 |
| Jun 26, 2026 | PICKERING GRANT | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 24,237 | $55.22 | $1.34M | 468,020 |
| Jun 18, 2026 | GUGGENHIME ANDREW | officer: PRESIDENT AND CFO | Sell | 10,000 | $53.00 | $530.0K | 104,395 |
| Jun 18, 2026 | PICKERING GRANT | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 23,461 | $52.50 | $1.23M | 496,939 |
| May 1, 2026 | Wassil Jim | officer: CHIEF OPERATING OFFICER | Sell | 2,250 | $56.83 | $127.9K | 160,744 |
| Apr 8, 2026 | Cowan Elvia | officer: SVP, Finance & CAO | Sell | 3,000 | $60.00 | $180.0K | 28,975 |
| Mar 18, 2026 | Cowan Elvia | officer: SVP, Finance & CAO | Sell | 1,892 | $55.57 | $105.1K | 29,380 |
| Mar 11, 2026 | Cowan Elvia | officer: SVP, Finance & CAO | Sell | 2,500 | $58.59 | $146.5K | 30,867 |
| Mar 11, 2026 | Wassil Jim | officer: CHIEF OPERATING OFFICER | Sell | 7,395 | $58.88 | $435.4K | 171,786 |
| Sep 8, 2025 | Dhaliwal Harpreet S. | Chief Technical Ops Officer | Sell | 1,204 | $32.41 | $39.0K | 0 |
| Sep 2, 2025 | Dhaliwal Harpreet S. | Chief Technical Ops Officer | Sell | 1,538 | $31.56 | $48.5K | 0 |
| Sep 2, 2025 | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 5,080 | $31.56 | $160.3K | 0 |
| Feb 27, 2025 | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 9,997 | $72.29 | $722.6K | 0 |
| Feb 27, 2025 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 15,154 | $72.97 | $1.11M | 0 |
| Feb 19, 2025 | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $83.85 | $670.8K | 111,309 |
| Feb 7, 2025 | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $90.07 | $450.4K | 32,651 |
| Feb 4, 2025 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $86.22 | $689.8K | 208,381 |
| Jan 22, 2025 | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $86.51 | $692.1K | 112,173 |
| Jan 17, 2025 | Loxam Teri | Director | Sell | 6,250 | $85.11 | $532.0K | 13,279-32% |
| Jan 7, 2025 | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $85.58 | $427.9K | 32,268 |
| Jan 3, 2025 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $83.66 | $669.3K | 212,339 |
| Dec 19, 2024 | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $88.78 | $710.2K | 116,301 |
| Dec 10, 2024 | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 2,366 | $92.25 | $218.3K | 136,437 |
| Dec 9, 2024 | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $91.49 | $457.4K | 32,262 |
| Dec 3, 2024 | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 15,000 | $92.45 | $1.39M | 453,952 |
| Dec 3, 2024 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $92.49 | $739.9K | 207,923 |
| Nov 19, 2024 | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $85.81 | $686.5K | 111,380 |
| Nov 8, 2024 | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 2,366 | $103.89 | $245.8K | 138,354 |
| Nov 6, 2024 | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $106.36 | $531.8K | 32,835 |
| Nov 4, 2024 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $106.80 | $854.4K | 208,740 |
| Nov 4, 2024 | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 15,000 | $106.82 | $1.60M | 440,264 |
| Oct 22, 2024 | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 42,000 | $115.39 | $4.85M | 96,269-30% |
| Oct 8, 2024 | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $109.27 | $546.4K | 33,147 |
| Oct 8, 2024 | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 7,098 | $109.21 | $775.2K | 141,820 |
| Oct 3, 2024 | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,500 | $114.24 | $628.3K | 32,709 |
| Oct 3, 2024 | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 55,000 | $114.25 | $6.28M | 465,914 |
| Oct 3, 2024 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $114.24 | $913.9K | 206,334 |
| Sep 19, 2024 | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $115.94 | $927.5K | 92,898 |
| Sep 18, 2024 | Loxam Teri | Director | Sell | 6,250 | $116.28 | $726.7K | 13,184-32% |
| Sep 18, 2024 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 10,000 | $115.96 | $1.16M | 210,174 |
| Sep 5, 2024 | Cowan Elvia | SVP, FINANCE | Sell | 5,000 | $107.67 | $538.4K | 12,723-28% |
| Sep 5, 2024 | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 1,667 | $112.11 | $186.9K | 32,489 |
| Sep 5, 2024 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 10,000 | $111.93 | $1.12M | 217,245 |
Showing 1–50 of 190
1 / 4
PCVX Insider Buying Activity
The following table shows recent insider purchases of Vaxcyte, Inc. (PCVX) stock reported via SEC Form 4 filings.
No insider buying activity found for PCVX in the last 12 months.
PCVX Insider Selling Activity
The following table shows recent insider sales of Vaxcyte, Inc. (PCVX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Wassil Jim | officer: EVP, Chief Scientific Ofc, COO | Sell | 2,715 | $60.35 | $163.9K | 152,228 |
| Sep 2, 2026 | Wassil Jim | officer: CHIEF OPERATING OFFICER | Sell | 3,477 | $61.07 | $212.4K | 156,981 |
| Aug 5, 2026 | Dhaliwal Harpreet S. | officer: Chief Technical Ops Officer | Sell | 17,000 | $55.00 | $935.1K | 76,756 |
| Aug 5, 2026 | GUGGENHIME ANDREW | officer: PRESIDENT AND CFO | Sell | 10,000 | $53.89 | $538.9K | 108,220 |
| Aug 5, 2026 | Wassil Jim | officer: CHIEF OPERATING OFFICER | Sell | 2,250 | $53.86 | $121.2K | 158,930 |
| Jul 28, 2026 | PICKERING GRANT | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 18,198 | $55.63 | $1.01M | 457,662 |
| Jul 6, 2026 | Wassil Jim | officer: CHIEF OPERATING OFFICER | Sell | 2,250 | $56.33 | $126.7K | 157,222 |
| Jul 6, 2026 | GUGGENHIME ANDREW | officer: PRESIDENT AND CFO | Sell | 10,000 | $57.28 | $572.8K | 106,482 |
| Jun 26, 2026 | PICKERING GRANT | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 24,237 | $55.22 | $1.34M | 468,020 |
| Jun 18, 2026 | GUGGENHIME ANDREW | officer: PRESIDENT AND CFO | Sell | 10,000 | $53.00 | $530.0K | 104,395 |
| Jun 18, 2026 | PICKERING GRANT | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 23,461 | $52.50 | $1.23M | 496,939 |
| May 1, 2026 | Wassil Jim | officer: CHIEF OPERATING OFFICER | Sell | 2,250 | $56.83 | $127.9K | 160,744 |
| Apr 8, 2026 | Cowan Elvia | officer: SVP, Finance & CAO | Sell | 3,000 | $60.00 | $180.0K | 28,975 |
| Mar 18, 2026 | Cowan Elvia | officer: SVP, Finance & CAO | Sell | 1,892 | $55.57 | $105.1K | 29,380 |
| Mar 11, 2026 | Cowan Elvia | officer: SVP, Finance & CAO | Sell | 2,500 | $58.59 | $146.5K | 30,867 |
| Mar 11, 2026 | Wassil Jim | officer: CHIEF OPERATING OFFICER | Sell | 7,395 | $58.88 | $435.4K | 171,786 |
| Sep 8, 2025 | Dhaliwal Harpreet S. | Chief Technical Ops Officer | Sell | 1,204 | $32.41 | $39.0K | 0 |
| Sep 2, 2025 | Dhaliwal Harpreet S. | Chief Technical Ops Officer | Sell | 1,538 | $31.56 | $48.5K | 0 |
| Sep 2, 2025 | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 5,080 | $31.56 | $160.3K | 0 |
| Feb 27, 2025 | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 9,997 | $72.29 | $722.6K | 0 |
| Feb 27, 2025 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 15,154 | $72.97 | $1.11M | 0 |
| Feb 19, 2025 | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $83.85 | $670.8K | 111,309 |
| Feb 7, 2025 | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $90.07 | $450.4K | 32,651 |
| Feb 4, 2025 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $86.22 | $689.8K | 208,381 |
| Jan 22, 2025 | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $86.51 | $692.1K | 112,173 |
| Jan 17, 2025 | Loxam Teri | Director | Sell | 6,250 | $85.11 | $532.0K | 13,279-32% |
| Jan 7, 2025 | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $85.58 | $427.9K | 32,268 |
| Jan 3, 2025 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $83.66 | $669.3K | 212,339 |
| Dec 19, 2024 | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $88.78 | $710.2K | 116,301 |
| Dec 10, 2024 | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 2,366 | $92.25 | $218.3K | 136,437 |
| Dec 9, 2024 | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $91.49 | $457.4K | 32,262 |
| Dec 3, 2024 | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 15,000 | $92.45 | $1.39M | 453,952 |
| Dec 3, 2024 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $92.49 | $739.9K | 207,923 |
| Nov 19, 2024 | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $85.81 | $686.5K | 111,380 |
| Nov 8, 2024 | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 2,366 | $103.89 | $245.8K | 138,354 |
| Nov 6, 2024 | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $106.36 | $531.8K | 32,835 |
| Nov 4, 2024 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $106.80 | $854.4K | 208,740 |
| Nov 4, 2024 | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 15,000 | $106.82 | $1.60M | 440,264 |
| Oct 22, 2024 | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 42,000 | $115.39 | $4.85M | 96,269-30% |
| Oct 8, 2024 | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,000 | $109.27 | $546.4K | 33,147 |
| Oct 8, 2024 | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 7,098 | $109.21 | $775.2K | 141,820 |
| Oct 3, 2024 | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 5,500 | $114.24 | $628.3K | 32,709 |
| Oct 3, 2024 | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | Sell | 55,000 | $114.25 | $6.28M | 465,914 |
| Oct 3, 2024 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 8,000 | $114.24 | $913.9K | 206,334 |
| Sep 19, 2024 | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | 8,000 | $115.94 | $927.5K | 92,898 |
| Sep 18, 2024 | Loxam Teri | Director | Sell | 6,250 | $116.28 | $726.7K | 13,184-32% |
| Sep 18, 2024 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 10,000 | $115.96 | $1.16M | 210,174 |
| Sep 5, 2024 | Cowan Elvia | SVP, FINANCE | Sell | 5,000 | $107.67 | $538.4K | 12,723-28% |
| Sep 5, 2024 | Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC | Sell | 1,667 | $112.11 | $186.9K | 32,489 |
| Sep 5, 2024 | Wassil Jim | CHIEF OPERATING OFFICER | Sell | 10,000 | $111.93 | $1.12M | 217,245 |
PCVX Insiders
Similar Stocks to PCVX
VRTX
Vertex Pharmaceuticals Incorporated
$513.52-1.17%
$132.26B
REGN
Regeneron Pharmaceuticals, Inc.
$772.87-2.63%
$83.21B
MRNA
Moderna, Inc.
$142.93-2.49%
$57.13B
RVMD
Revolution Medicines, Inc.
$204.47-0.31%
$44.15B
INSM
Insmed Incorporated
$119.56-4.63%
$28.05B
INCY
Incyte Corporation
$121.65-0.43%
$24.62B
UTHR
United Therapeutics Corporation
$500.44-0.42%
$21.10B
NBIX
Neurocrine Biosciences, Inc.
$150.44-4.31%
$15.71B